Announcement on Progress in Drug Clinical Trials of Subsidiary
Filed with SSE · · 2 pages · Chinese
Beijing Tiantan Biological Products Corporation Limited on 6ix
Earlier from Beijing Tiantan Biological Products
- Announcement on the Change of Sponsor Representative for Continuous Supervision
- Announcement on Changing Signatory Certified Public Accountant
- Announcement on 2024 Annual Preliminary Earnings Estimate
- Announcement on Subsidiary Obtaining Summary Report on Clinical Trial
- Announcement on Asset Leasing and Related Party Transactions
Later from Beijing Tiantan Biological Products
- Announcement on Subsidiary Re-obtaining High-tech Enterprise Certificate
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Preliminary Earnings Estimate for Q1 2025
- Notice on Convening the 2024 Annual General Meeting
- Announcement on Convening 2024 Annual Performance and Cash Dividend Meeting
Follow Beijing Tiantan Biological Products into a list and get an email when it puts out news.
Follow Beijing Tiantan Biological Products